» Articles » PMID: 7702029

Altered Antioxidant Status and Increased Lipid Peroxidation in Children with Cystic Fibrosis

Overview
Journal Am J Clin Nutr
Publisher Elsevier
Date 1995 Apr 1
PMID 7702029
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Cystic fibrosis often combines an infectious pathology with a syndrome of malabsorption, both potentially capable of favoring the deleterious effects of reactive oxygen species. This study was a simultaneous evaluation of the main antioxidant systems dependent on micronutrients and of lipid peroxidation products in 27 children with cystic fibrosis and 17 healthy children. Plasma of cystic fibrosis patients showed very low concentrations of beta-carotene (0.30 +/- 0.2 vs 1.63 +/- 0.5 mumol/g cholesterol, P < 0.0001) and a lower activity of selenium-dependent glutathione peroxidase (263.6 +/- 42 vs 296.9 +/- 57 U/L, P = 0.028). In parallel, the higher plasma concentrations of organic hydroperoxides (171.5 +/- 54.4 vs 122.6 +/- 23.3 mumol/L, P = 0.001) and of thiobarbituric acid reactants (2.9 +/- 0.6 vs 2.4 +/- 0.3 mumol/L, P = 0.004) reflected oxidative stress in this pathology. In addition, in these patients the major substrates of lipoperoxidation were significantly lower, whether they be linoleic acid (2.26 +/- 0.8 vs 3.60 +/- 0.9 mmol/L, P < 0.0001) or arachidonic acid (0.55 +/- 0.2 vs 0.74 +/- 0.2 mmol/L, P = 0.006). These results suggested that nutritional deficiencies resulting from malabsorption could considerably amplify disorders related to toxicity of reactive oxygen species. These nutritional deficits could also be aggravated by the destruction of antioxidant compounds by the inflammatory process.

Citing Articles

Systemic oxidative stress in children with cystic fibrosis with bacterial infection including Pseudomonas Aeruginosa.

Bennemann G, Moreira E, Pereira L, de Freitas M, de Oliveira D, Ventura J Clin Respir J. 2022; 16(6):475-483.

PMID: 35753706 PMC: 9366585. DOI: 10.1111/crj.13513.


Increased susceptibility of cystic fibrosis airway epithelial cells to ferroptosis.

Maniam P, Essilfie A, Kalimutho M, Ling D, Frazer D, Phipps S Biol Res. 2021; 54(1):38.

PMID: 34903297 PMC: 8670191. DOI: 10.1186/s40659-021-00361-3.


Antioxidant supplementation for lung disease in cystic fibrosis.

Ciofu O, Smith S, Lykkesfeldt J Cochrane Database Syst Rev. 2019; 10:CD007020.

PMID: 31580490 PMC: 6777741. DOI: 10.1002/14651858.CD007020.pub4.


Supplementation with red palm oil increases β-carotene and vitamin A blood levels in patients with cystic fibrosis.

Sommerburg O, De Spirt S, Mattern A, Joachim C, Langhans C, Nesaretnam K Mediators Inflamm. 2015; 2015:817127.

PMID: 25688177 PMC: 4321850. DOI: 10.1155/2015/817127.


Cystic fibrosis-related diabetes: from CFTR dysfunction to oxidative stress.

NTimbane T, Comte B, Mailhot G, Berthiaume Y, Poitout V, Prentki M Clin Biochem Rev. 2009; 30(4):153-77.

PMID: 20011209 PMC: 2791770.